The pharmaceutical world is witnessing a significant shift in diabetes therapy with the introduction of GLP-1 patches. These patches offer a seemingly more user-friendly alternative to shots of GLP-1 drugs, reducing the requirement of daily needle pricks. The innovation releases the drug directly through the epidermis, arguably improving patient… Read More